Author:
Rotstein Samuel,Blomgren Henric,Petrini Björn,Wasserman Jerzy,von Stedingk Lars-Victor
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Baum M, Brinkley DM, Dossett JA: Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex adjuvant trial organisation. Lancet i: 836–840, 1985
2. Ribeiro G, Swindell R: The Christie Hospital tamoxifen (Nolvadex) adjuvant for operable breast carcinoma — 7 yrs results. Eur J Cancer Clin Oncol 21: 897–900, 1985
3. Fernandez MO, Alaghband-Zadeh J, Burn JI: Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability to response to endocrine therapy. Clin Oncol 9: 245–250, 1983
4. Paridaens R, Sylvester RJ, Ferazzi E, Legros N, Leclercq G, heuson JC: Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46: 2889–2895, 1980
5. Rose C, Thorpe SM, Lørben J, Daenfeldt JL, Palshof T, Mouridsen HT: Therapeutic effect of tamoxifen related to estrogen level. In: Henningsen B, Linder F, Steichile C (eds) Endocrine treatment of breast cancer. Springer-Verlag, Berlin-Heidelberg-New York, 1980, pp 134–141
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献